Isolated Lateralized Overgrowth - Phenotypic Spectrum and Molecular Alterations

Overview

Journal Indian J Pediatr

Specialty Pediatrics

Date 2024 Oct 19

PMID 39425824

Authors

Sakshi Yadav

R C Madhumita

Neerja Gupta

Sandeepa Chauhan

Shweta Kusmakar

Prahlad Balakrishnan

Manisha Jana

Ratna D Puri

Shubha R Phadke

Madhulika Kabra

Affiliations

Soon will be listed here.

Abstract

Objectives: To evaluate the molecular aberrations at 11p15.5 locus in thirty-two patients with isolated lateralized overgrowth (ILO).

Methods: Among selected 32 cases of ILO, methylation-sensitive multiplex ligation-dependent probe amplification (MS-MLPA) was performed initially followed by short tandem repeats (STR) marker analysis to confirm uniparental disomy (UPD). In those patients with normal MLPA reports, cyclin dependent kinase inhibitor 1C (CDKN1C) gene and whole exome sequencing was performed.

Results: Molecular analysis by MS-MLPA showed methylation aberrations in 28% (9/32) of patients. Gain of methylation at IC1 imprinting center (H4, H7) and loss of methylation at IC2 (H6, H9) was observed in 2 patients each. Uniparental disomy was observed in 9% cases. Except one, all patients with methylation aberration had more than one limb hypertrophy. Two patients (H22/H29) also had loss of methylation at IC1. Though this molecular alteration is specifically associated with Silver Russel syndrome (SRS), but the affected children did not completely fulfill the diagnostic criteria for SRS. In a recent study, a discrepancy was reported between the diagnosis of Beckwith-Wiedemann syndrome (BWS)/SRS and the molecular findings in the patients. Many times, it is very difficult to differentiate between hemi hypertrophy/hemi hypotrophy. Patients, in whom no aberrations were detected on MS-MLPA, whole exome sequencing (WES) was performed and no pathogenic variant was identified.

Conclusions: Thus, ILO may be considered as a mild presentation on the extreme edge of BWS spectrum with methylation aberration and UPD in one third of cases which has implications in follow up.

References

Hoyme H, Seaver L, Jones K, Procopio F, Crooks W, Feingold M . Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review. Am J Med Genet. 1998; 79(4):274-8. View

Vaiman M, Shilco P, Roitblat Y, Padilla-Raygoza N, Leit A, Kavin A . Screening Procedure for Hemihypertrophy: Preliminary Results of International Multicenter Prospective Study. Cent Asian J Glob Health. 2019; 8(1):336. PMC: 6564096. DOI: 10.5195/cajgh.2019.336. View

Kalish J, Biesecker L, Brioude F, Deardorff M, Di Cesare-Merlone A, Druley T . Nomenclature and definition in asymmetric regional body overgrowth. Am J Med Genet A. 2017; 173(7):1735-1738. PMC: 5932268. DOI: 10.1002/ajmg.a.38266. View

Weksberg R, Shuman C, Beckwith J . Beckwith-Wiedemann syndrome. Eur J Hum Genet. 2009; 18(1):8-14. PMC: 2987155. DOI: 10.1038/ejhg.2009.106. View

Martin R, Grange D, Zehnbauer B, DeBaun M . LIT1 and H19 methylation defects in isolated hemihyperplasia. Am J Med Genet A. 2005; 134A(2):129-31. DOI: 10.1002/ajmg.a.30578. View

Shuman C, Smith A, Steele L, Ray P, Clericuzio C, Zackai E . Constitutional UPD for chromosome 11p15 in individuals with isolated hemihyperplasia is associated with high tumor risk and occurs following assisted reproductive technologies. Am J Med Genet A. 2006; 140(14):1497-503. DOI: 10.1002/ajmg.a.31323. View

Weksberg R, Shuman C, Smith A . Beckwith-Wiedemann syndrome. Am J Med Genet C Semin Med Genet. 2005; 137C(1):12-23. DOI: 10.1002/ajmg.c.30058. View

Romanelli V, Belinchon A, Benito-Sanz S, Martinez-Glez V, Gracia-Bouthelier R, Heath K . CDKN1C (p57(Kip2)) analysis in Beckwith-Wiedemann syndrome (BWS) patients: Genotype-phenotype correlations, novel mutations, and polymorphisms. Am J Med Genet A. 2010; 152A(6):1390-7. DOI: 10.1002/ajmg.a.33453. View

Lam W, Hatada I, Ohishi S, Mukai T, Joyce J, Cole T . Analysis of germline CDKN1C (p57KIP2) mutations in familial and sporadic Beckwith-Wiedemann syndrome (BWS) provides a novel genotype-phenotype correlation. J Med Genet. 1999; 36(7):518-23. PMC: 1734395. View

10.

Zerbino D, Achuthan P, Akanni W, Amode M, Barrell D, Bhai J . Ensembl 2018. Nucleic Acids Res. 2017; 46(D1):D754-D761. PMC: 5753206. DOI: 10.1093/nar/gkx1098. View

11.

Landrum M, Lee J, Benson M, Brown G, Chao C, Chitipiralla S . ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 2015; 44(D1):D862-8. PMC: 4702865. DOI: 10.1093/nar/gkv1222. View

12.

Welter D, MacArthur J, Morales J, Burdett T, Hall P, Junkins H . The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 2013; 42(Database issue):D1001-6. PMC: 3965119. DOI: 10.1093/nar/gkt1229. View

13.

Sherry S, Ward M, Kholodov M, Baker J, Phan L, Smigielski E . dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2000; 29(1):308-11. PMC: 29783. DOI: 10.1093/nar/29.1.308. View

14.

Azzi S, Salem J, Thibaud N, Chantot-Bastaraud S, Lieber E, Netchine I . A prospective study validating a clinical scoring system and demonstrating phenotypical-genotypical correlations in Silver-Russell syndrome. J Med Genet. 2015; 52(7):446-53. PMC: 4501172. DOI: 10.1136/jmedgenet-2014-102979. View

15.

Mark C, Hart C, McCarthy A, Thompson A . Fifteen-minute consultation: Assessment, surveillance and management of hemihypertrophy. Arch Dis Child Educ Pract Ed. 2017; 103(3):114-117. DOI: 10.1136/archdischild-2017-312645. View

16.

Priyamvada P, Parameswaran S, Sandeep M, Shankar V, Swaminathan R . Medullary sponge kidney and isolated hemihyperplasia. Indian J Nephrol. 2014; 24(4):243-5. PMC: 4119338. DOI: 10.4103/0971-4065.133013. View

17.

Ibrahim A, Kirby G, Hardy C, Dias R, Tee L, Lim D . Methylation analysis and diagnostics of Beckwith-Wiedemann syndrome in 1,000 subjects. Clin Epigenetics. 2014; 6(1):11. PMC: 4064264. DOI: 10.1186/1868-7083-6-11. View

18.

Mussa A, Russo S, De Crescenzo A, Freschi A, Calzari L, Maitz S . (Epi)genotype-phenotype correlations in Beckwith-Wiedemann syndrome. Eur J Hum Genet. 2015; 24(2):183-90. PMC: 4717210. DOI: 10.1038/ejhg.2015.88. View

19.

DeBaun M, Niemitz E, McNeil D, Brandenburg S, Lee M, Feinberg A . Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Hum Genet. 2002; 70(3):604-11. PMC: 384940. DOI: 10.1086/338934. View

20.

Radley J, Connolly M, Sabir A, Kanani F, Carley H, Jones R . Isolated- and Beckwith-Wiedemann syndrome related- lateralised overgrowth (hemihypertrophy): Clinical and molecular correlations in 94 individuals. Clin Genet. 2021; 100(3):292-297. DOI: 10.1111/cge.13997. View